Switch to:

Beam Therapeutics Total Equity

: $261.39 Mil (As of Mar. 2020)
View and export this data going back to 2020. Start your Free Trial

Beam Therapeutics's total equity for the quarter that ended in Mar. 2020 was $261.39 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.


Beam Therapeutics Total Equity Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Beam Therapeutics Annual Data
Dec17 Dec18 Dec19
Total Equity -4.18 134.03 100.95

Beam Therapeutics Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20
Total Equity Premium Member Only Premium Member Only 0.00 143.65 126.72 100.95 261.39

Beam Therapeutics Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Beam Therapeutics's Total Equity for the fiscal year that ended in Dec. 2019 is calculated as

Total Equity=Total Assets(Q: Dec. 2019 )-Total Liabilities(Q: Dec. 2019 )
=156.099-55.154
=100.95

Beam Therapeutics's Total Equity for the quarter that ended in Mar. 2020 is calculated as

Total Equity=Total Assets(Q: Mar. 2020 )-Total Liabilities(Q: Mar. 2020 )
=322.638-61.244
=261.39

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Beam Therapeutics Total Equity Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)